Editor's note: While CMS does seem
to be acknowledging that ESA overuse has been a
significant cause of morbidity and mortality, it
is disappointing that CMS continues to target biochemical
markers instead of life outcomes. Few realize it,
but the two outcomes they are still targeting with
URR are "not dead and not in the hospital."
If patients aren't getting enough dialysis to feel
well enough to live productive and meaningful lives,
the federal ESRD program will continue to be a factory
for debilitation and disability.
There is a growing hypocrisy in the dialysis industry
in that the CEOs and nephrologists of the major
corporations would want much more dialysis therapy
for themselves (double or more!)
than their average patient receives.
Editor's note: I believe the fact
sheet should also state that you can likely reduce
the amount of ESAs you will require if you receive
longer and more frequent hemodialysis treatments.
Except
where noted, no material within the RenalWEB web sites can be copied,
duplicated, or reproduced in any form without written consent from RenalWEB.